Compliance Clock Starts Ticking Under Historic Modernization of Cosmetic Regulations Act
Executive Summary
Companies have one year to comply with US FDA registration and product listing requirements under the Modernization of Cosmetic Regulations Act of 2022, part of the $1.7tr omnibus spending package signed by President Joe Biden on 29 December. Trade groups applauded the historic milestone and the legislation’s departure from previous proposals, including the elimination of user fees.
You may also be interested in...
Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later
Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.
MoCRA Confidentiality For AE Reports? And Other Questions Raised At IBA Regulatory Forum
Independent Beauty Association president and CEO Don Frey, Kerry Tassopoulos of Platt Cheema Richmond PLLC, and IBA board member and Co-CEO and president Craig Weiss of the Consumer Product Testing Company fielded questions on MoCRA implementation at IBA’s 2023 Technical/Regulatory Forum.
MoCRA: No User Fees, Not Overly Prescriptive, And Could Help Tamp Down State Legislation
Independent Beauty Association CEO and president Don Frey and cosmetics industry lobbyist Robert Harmala of Telegraph Avenue Advisor, provided views on the Modernization of Cosmetic Regulations Act and developments to come at IBA’s Cosmetic Technical/Regulatory Forum.